Eli Lilly and Company (LLY) vs Roche Holding AG (RO.SW)

See how Eli Lilly and Company and Roche Holding AG differ across market data and performance, so you can decide which asset best fits your strategy.

$1,227.94
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$454.43
Swiss
Roche Holding AG is a publicly traded company. It is a Swiss healthcare company focused on pharmaceuticals and diagnostics, including oncology, immunology, neuroscience, infectious disease, and laboratory testing. The company's performance is influenced by revenue growth, margins, capital allocation, competitive positioning, regulation, currency movements where relevant, and broader economic and market conditions affecting its industry.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.095T
Price
$1,227.94
24h Change
+2.54%
24h Volume
$756.5K
Employees
50,000
Shares Outstanding
944,818,881
Roche Holding AGRO.SW
Market Cap
$362.073B
Price
$454.43
24h Change
+1.92%
24h Volume
$13.1K
Employees
N/A
Shares Outstanding
N/A

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
75.2%
RO.SW
24.8%

Volume Share

Share of combined 24h volume

Volume Share
LLY
98.3%
RO.SW
1.7%

24h Performance

Price change over last 24 hours

24h Performance
LLY
2.54%
RO.SW
1.92%
Price Comparison
Eli Lilly and Company
Roche Holding AG